Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MedPAC Draft Recommendations Aim To Control Imaging Proliferation

This article was originally published in The Gray Sheet

Executive Summary

Favorable reimbursement for imaging services has contributed to inappropriate use, according to MedPAC commissioner Nicholas Wolter, MD, Deaconess Billings Clinic in Billings, Mont

You may also be interested in...



MedPAC’s March Report To Feature Recommendations To Curtail Imaging Use

Providers billing Medicare for performing diagnostic imaging services and interpreting test results should be subject to standards set by the HHS Secretary, according to the Medicare Payment Advisory Commission

MedPAC’s March Report To Feature Recommendations To Curtail Imaging Use

Providers billing Medicare for performing diagnostic imaging services and interpreting test results should be subject to standards set by the HHS Secretary, according to the Medicare Payment Advisory Commission

MedPAC Calls For DRG Refinement, Specialty Hospital Moratorium Extension

Medicare hospital inpatient reimbursement accuracy should be improved by refining current diagnosis-related groups to "more fully capture differences in severity of illness among patients," according to the Medicare Payment Advisory Commission

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel